Charles Liles | Head of Investor Relations |
Bassil Dahiyat | President and Chief Executive Officer |
Allen Yeng | Chief Medical Officer |
John Desjarlais | Chief Scientific Officer |
John Kuch | Chief Financial Officer |
Edward Tenthoff | Piper Sandler & Co. |
Elisa Young | Cantor Fitzgerald |
Jonathan Chen | SVB Leerink |
Mara Goldstein | Mizuho |
Etzer Darout | Guggenheim Securities |
Arlinda Lee | Canaccord |
Gregory Renza | RBC Capital Markets |
Thomas Shrader | BTIG |
Dane Leone | Raymond James |
Peter Lawson | Barclays |
Good afternoon ladies and gentlemen, thank you for standing by and welcome to the Second Quarter 2020 Xencor Conference Call. [Operator Instructions] Now I would now like to turn the call to your speaker today, Charles Liles, Head of Investor Relations. Thank you and good afternoon.
Thank you, and good afternoon. Earlier today, we issued a press release which outlines the topics we plan to discuss today.